Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuroendocrinology ; 107(4): 340-354, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30208370

RESUMO

BACKGROUND/AIMS: Abuse of toluene products (e.g., glue-sniffing) primarily occurs during adolescence and has been associated with appetite suppression and weight impairments. However, the metabolic phenotype arising from adolescent inhalant abuse has never been fully characterised, and its persistence during abstinence and underlying mechanisms remain unknown. METHODS: Adolescent male Wistar rats (post-natal day 27) were exposed to inhaled toluene (10,000 ppm) (n = 32) or air (n = 48) for 1 h/day, 3 days/week for 4 weeks, followed by 4 weeks of abstinence. Twenty air rats were pair-fed to the toluene group, to differentiate the direct effects of toluene from under-nutrition. Food intake, weight, and growth were monitored. Metabolic hormones were measured after exposure and abstinence periods. Energy expenditure was measured using indirect calorimetry. Adrenal function was assessed using adrenal histology and hormone testing. RESULTS: Inhalant abuse suppressed appetite and increased energy expenditure. Reduced weight gain and growth were observed in both the toluene and pair-fed groups. Compared to the pair-fed group, and despite normalisation of food intake, the suppression of weight and growth for toluene-exposed rats persisted during abstinence. After exposure, toluene-exposed rats had low fasting blood glucose and insulin compared to the air and pair-fed groups. Consistent with adrenal insufficiency, adrenal hypertrophy and increased basal adrenocorticotropic hormone were observed in the toluene-exposed rats, despite normal basal corticosterone levels. CONCLUSIONS: Inhalant abuse results in negative energy balance, persistent growth impairment, and endocrine changes suggestive of adrenal insufficiency. We conclude that adrenal insufficiency contributes to the negative energy balance phenotype, potentially presenting a significant additional health risk for inhalant users.


Assuntos
Doenças das Glândulas Suprarrenais/induzido quimicamente , Transtornos do Crescimento/induzido quimicamente , Abuso de Inalantes/complicações , Doenças Metabólicas/induzido quimicamente , Maturidade Sexual , Adolescente , Comportamento do Adolescente/efeitos dos fármacos , Comportamento do Adolescente/fisiologia , Desenvolvimento do Adolescente/efeitos dos fármacos , Doenças das Glândulas Suprarrenais/metabolismo , Doenças das Glândulas Suprarrenais/fisiopatologia , Glândulas Suprarrenais/fisiopatologia , Animais , Apetite/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Modelos Animais de Doenças , Ingestão de Alimentos/efeitos dos fármacos , Transtornos do Crescimento/metabolismo , Transtornos do Crescimento/fisiopatologia , Humanos , Abuso de Inalantes/metabolismo , Abuso de Inalantes/patologia , Abuso de Inalantes/fisiopatologia , Masculino , Doenças Metabólicas/metabolismo , Doenças Metabólicas/fisiopatologia , Atividade Motora/efeitos dos fármacos , Fenótipo , Ratos , Ratos Wistar , Maturidade Sexual/efeitos dos fármacos , Maturidade Sexual/fisiologia , Tolueno/toxicidade
2.
Neurotoxicol Teratol ; 34(1): 37-46, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22074881

RESUMO

Inhalation of vapors from toluene-containing products results in euphoria accompanied by a variety of cognitive impairments and motor dysfunctions. The profound behavioral changes observed during and following toluene inhalation suggest changes in the activity of cells in potentially many brain regions; however, a comprehensive assessment of the neuroanatomical structures activated by toluene vapor has not been completed. Thus in the present study we systematically mapped in over 140 brain structures the distribution of c-Fos immunoreactivity (c-Fos IR), a proxy for neural activation, following exposure to an abuse-like concentration (~5000 ppm) of toluene vapor for 0, 5, 10 or 30 min. Quantitative analyses revealed increases in c-Fos IR in about one-third of the brain structures examined, with most of these structures significantly activated only after prolonged toluene exposure. The majority of brain structures activated by toluene were found in the forebrain and midbrain, with particularly pronounced activation in nuclei implicated in the processing of rewarding, emotional, and olfactory stimuli, and those controlling motor output. These structures included the ventral tegmental area, nucleus accumbens, select regions of the amygdala and hypothalamus, cingulate cortex, olfactory nuclei, piriform cortex, secondary motor cortex and caudate-putamen. In contrast, all subregions of the hippocampus and most thalamic nuclei were not significantly activated by toluene vapor. In the brainstem, effects of toluene vapor were restricted to select nuclei in the pons. The pattern of c-Fos IR evoked by inhalation of toluene vapor appears distinct from other psychoactive substances, consistent with the unique and complex behavioral outcomes associated with acute toluene inhalation.


Assuntos
Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Modelos Animais de Doenças , Abuso de Inalantes/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Tolueno/toxicidade , Doença Aguda , Administração por Inalação , Animais , Comportamento Animal/fisiologia , Biomarcadores/metabolismo , Encéfalo/fisiopatologia , Imuno-Histoquímica , Abuso de Inalantes/diagnóstico , Abuso de Inalantes/fisiopatologia , Masculino , Ratos , Ratos Sprague-Dawley , Solventes/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...